Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q2

6960.TEDINET S100PJZR
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥62.6bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥61.7bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥11.1bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥10.4bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥11.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥10.7bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥11.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥11.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥7.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥7.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥196.9bnat 2022-09-30Cons.Assets
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥183.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥41.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥155.1bnat 2022-09-30Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥142.9bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥66.4bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥63.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥61.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥52.5bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥53.6bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥11.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥6.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥4.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥536.852022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥348.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1,072.382021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥495.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥312.32021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio78.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥881m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥11.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥16.2bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥16.2bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.2bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥27.0bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥27.0bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.5bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥6.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥6.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥12.3bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥12.3bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥61.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥61.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥10.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 528
ItemContextValueUnit
Loss on investments in partnership noePrior1YTDDuration4000000JPY
Loss on investments in partnership noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration6000000JPY
Other noeCurrentYTDDuration4000000JPY
Non operating expensesPrior1YTDDuration29000000JPY
Non operating expensesCurrentYTDDuration22000000JPY
Ordinary incomePrior1YTDDuration10650000000JPY
Ordinary incomeCurrentYTDDuration11662000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration7000000JPY
Gain on sales of investment securities eiPrior1YTDDuration60000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Surrender value of insurance eiPrior1YTDDuration469000000JPY
Surrender value of insurance eiCurrentYTDDuration163000000JPY
Gain on extinguishment of tie in shares eiPrior1YTDDuration－JPY
Gain on extinguishment of tie in shares eiCurrentYTDDuration67000000JPY
Extraordinary incomePrior1YTDDuration531000000JPY
Extraordinary incomeCurrentYTDDuration239000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration0JPY
Impairment loss elPrior1YTDDuration13000000JPY
Impairment loss elCurrentYTDDuration58000000JPY
Loss on valuation of investment securities elPrior1YTDDuration153000000JPY
Loss on valuation of investment securities elCurrentYTDDuration48000000JPY
Office transfer expenses elPrior1YTDDuration33000000JPY
Office transfer expenses elCurrentYTDDuration－JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration200000000JPY
Extraordinary lossCurrentYTDDuration108000000JPY
Income before income taxesPrior1YTDDuration10980000000JPY
Income before income taxesCurrentYTDDuration11792000000JPY
Income taxes currentPrior1YTDDuration3252000000JPY
Income taxes currentCurrentYTDDuration3576000000JPY
Income taxes deferredPrior1YTDDuration234000000JPY
Income taxes deferredCurrentYTDDuration97000000JPY
Income taxesPrior1YTDDuration3486000000JPY
Income taxesCurrentYTDDuration3673000000JPY
Profit lossPrior1YTDDuration7493000000JPY
Profit lossCurrentYTDDuration8119000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration7493000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration8119000000JPY
Profit lossPrior1YTDDuration7493000000JPY
Profit lossCurrentYTDDuration8119000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration399000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-141000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration53000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration403000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration17000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration21000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass